Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neostigmine vs Sugammadex on Renal Function in Laparoscopic Cholecystectomy
NCT06081738Phase 4Unknown
- Sponsor
- Menoufia University
- Start
- Mar 2023
- Primary completion
- Sep 2023
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Sugammadex in neuromuscular blockade (NMB) (2 arms), sponsored by Menoufia University. Primary endpoint: Neutrophil Gelatinase Associated Lipocalin. Status: unknown.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT06081738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06081738.